From: A framework for developing an evidence-based, comprehensive tobacco control program
 | MPOWER | CDC Best Practices | Institute of Medicine | Framework Convention for Tobacco Control |
---|---|---|---|---|
MONITORING AND RESEARCH | √ | √ |  | √ |
Monitor prevalence of tobacco use | √ | √ |  | Article 20 |
Monitor attitudes, knowledge, or social norms |  | √ |  | Article 20 |
Monitor tobacco industry marketing, promotion and lobbying | √ |  |  | Article 20 |
Monitor tobacco production and manufacture | Â | Â | Â | Article 20 |
Monitor policies, impact of policies | √ | √ |  | Article 20 |
Assess effectiveness and impact of programs | √ | √ |  | Article 20 |
Research on consequences of tobacco use and exposure |  | √ |  | Article 20 |
Research on determinants of tobacco use and exposure | √ | √ |  | Article 20 |
Identification of alternative crops | Â | Â | Â | Article 20 |
PROTECT PEOPLE FROM SECONDHAND SMOKE | √ | √ (Details left to States) | √ | √ |
Prohibition of smoking in all indoor non-residential environments | √ |  | √ | Article 8 |
Full enforcement | √ |  |  |  |
Voluntary home smoking bans in homes with children | √ |  | √ |  |
Healthcare provider messages on SHS |  |  | √ |  |
Car bans with children passengers |  |  | √ |  |
Smoke-free apartment buildings |  |  | √ |  |
OFFER HELP TO QUIT (AND ENCOURAGE QUITTING) | √ | √ | √ | √ |
Medical advice | √ | √ | √ | Article 14 |
Pharmacotherapy | √ | √ | √ | Article 14 |
Quit lines | √ | √ | √ |  |
Counselling | √ | √ | √ | Article 14 |
Provider training/providing trained personnel | √ | √ | √ | Article 12 |
Subsidize costs | √ | √ | √ | Article 14 |
WARN ABOUT DANGERS | √ | √ | √ | √ |
Warn about dangers | √ | √ | √ | Article 12 |
Advertising campaigns about active smoking | √ | √ | √ |  |
Advertising campaigns about involuntary smoking | √ | √ |  |  |
Warnings on packs | √ |  | √ | Article 11. |
FDA authority to regulate warnings |  |  | √ |  |
YOUTH PREVENTION | √ | √ | √ | √ |
Funded school programs |  | √ | √ |  |
Media campaigns | √ | √ | √ |  |
Limit youth access |  | √ | √ | Article 16 |
COMMUNITY, STATE, FEDERAL, AND INTERNATIONAL ACTION | √ | √ | √ | √ |
Establishment of a coordinating body for tobacco control | Â | Â | Â | Article 5 |
Comprehensive state tobacco control programs |  | √ | √ |  |
Link with chronic disease programs |  | √ |  |  |
Identify tobacco-related disparities between population groups | √ | √ |  |  |
Create tobacco-free social norms |  | √ |  |  |
Funding strategy | √ | √ | √ | Article 26 |
Training and support for researchers | Â | Â | Â | Article 20 |
Cooperate with WHO on research, report and exchange of information; Cooperation in scientific, technical, and legal fields | Â | Â | Â | Article 20, 22 |
REGULATION AND LITIGATION | √ | √ | √ | √ |
Raise taxes/Prices | √ | √ | √ | Article 6 |
Enforced bans, bans, or restrictions on tobacco advertising, promotion, sponsorship | √ | √ | √ | Article 13 |
Regulation of manufacture, distribution, marketing, and use by FDA or other regulatory agency |  |  | √ | Articles 9, 15 |
Tobacco product disclosure |  |  | √ | Article 10 |
Disclosure of research by industry |  |  | √ |  |
Reduce nicotine level |  |  | √ |  |
Support for economically viable alternative activities | Â | Â | Â | Article 17 |
Litigation/Liability | Â | Â | Â | Article 19 |